Twareat Medical Care (9627) Fundamentals 2026 — Revenue Analysis | SniperIQ
Twareat Medical Care (9627) is a SA-listed Healthcare company in Medical - Care Facilities with a market capitalization of SAR 367M, trading at SAR 9.18 on the SAU. This SniperIQ fundamentals page covers Twareat Medical Care's valuation, profitability (net margin -5.6%), revenue (SAR 183M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Twareat Medical Care's market cap?
Twareat Medical Care (9627) has a market capitalization of approximately SAR 367M, trading at SAR 9.18 on the SAU. Market cap moves with the live share price.
What is Twareat Medical Care's P/E ratio?
Twareat Medical Care's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 7.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Twareat Medical Care?
Twareat Medical Care runs a net profit margin of -5.6%, a gross margin of 23.9%, and an operating margin of -3.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Twareat Medical Care generate?
Twareat Medical Care reported revenue of SAR 183M for fiscal year 2025, with net income of -SAR 10M and earnings per share (EPS) of -0.26. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Twareat Medical Care pay a dividend?
Twareat Medical Care does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Twareat Medical Care financially healthy?
Twareat Medical Care carries a debt-to-equity ratio of 0.65x and a current ratio of 1.44x, with a market beta of -0.18. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Twareat Medical Care a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Twareat Medical Care (9627) the key facts are: market cap SAR 367M, revenue SAR 183M, 52-week range 7.4-19.7. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Twareat Medical Care's full fundamentals live
Get Twareat Medical Care's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.